Global Search

Search articles, concepts, and chapters

Tang Guangxian

๐Ÿ‡ข๐Ÿ‡ญ First Hospital of Shijiazhuang
ORCIDOpenAlex14 articles in GJC

14 articles in GJC

4.

Two-year outcomes of combined surgical peripheral iridectomy, goniosynechialysis, and goniotomy for advanced primary angle-closure glaucoma without cataract: A multicenter study.

Lin Fengbin, Li Liu, Lu Ping, Tang Li, Zhang Yao, Xie Lin et al.

Asia Pac J Ophthalmol (Phila)Feb 20251 citationsCohort Study

Combined surgery (SPI+GSL+GT) for advanced PACG without cataract safely and effectively lowered IOP and medication use over two years, offering a viable alternative to trabeculectomy.

5.

Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study.

Gao Xinbo, Lin Fengbin, Lu Ping, Xie Lin, Tang Li, Zhu Xiaomin et al.

J GlaucomaMay 20247 citationsObservational Study

This study found combined SPI, GSL, and goniotomy is a safe, effective surgical option for advanced PACG without cataract, significantly lowering IOP and medication use, suggesting it's a potential first-line treatment.

6.

Impact of Peripheral Anterior Synechiae on the Outcome of Combined Phacoemulsification, Goniosynechialysis, and Goniotomy for Primary Angle Closure Glaucoma and Cataract: A Multicenter Observational Study.

Lin Fengbin, Zhang Yingzhe, Zhu Xiaomin, Yu Ping, Fan Sujie, Lv Aiguo et al.

J GlaucomaMay 20246 citationsObservational Study

Combined cataract surgery, goniosynechialysis, and goniotomy effectively treats primary angle closure glaucoma, with outcomes not dependent on the extent of preoperative peripheral anterior synechiae.

7.

Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial.

Feng Hui, Han Dong, Lu Wensheng, Tang Guangxian, Zhang Hengli, Fan Sujie et al.

Transl Vis Sci TechnolJan 20242 citationsRandomized Controlled Trial

This study compared morning vs. evening latanoprost/timolol for glaucoma; both reduced IOP, but morning dosing better controlled diurnal IOP fluctuations, offering guidance for clinical practice.

All 14 articles loaded